These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 1831366

  • 21. Cellular transformation by E1 genes of enteric adenoviruses.
    Cousin C, Winter N, Gomes SA, D'Halluin JC.
    Virology; 1991 Mar; 181(1):277-87. PubMed ID: 1825253
    [Abstract] [Full Text] [Related]

  • 22. The state of cellular differentiation determines the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer function.
    Herbst RS, Pelletier M, Boczko EM, Babiss LE.
    J Virol; 1990 Jan; 64(1):161-72. PubMed ID: 2136708
    [Abstract] [Full Text] [Related]

  • 23. Analysis of viral and cellular gene expression during progression and suppression of the transformed phenotype in type 5 adenovirus-transformed rat embryo cells.
    Duigou GJ, Su ZZ, Babiss LE, Driscoll B, Fung YK, Fisher PB.
    Oncogene; 1991 Oct; 6(10):1813-24. PubMed ID: 1923506
    [Abstract] [Full Text] [Related]

  • 24. Apoptosis mediates the selective toxicity of caffeic acid phenethyl ester (CAPE) toward oncogene-transformed rat embryo fibroblast cells.
    Su ZZ, Lin J, Prewett M, Goldstein NI, Fisher PB.
    Anticancer Res; 1995 Oct; 15(5B):1841-8. PubMed ID: 8572568
    [Abstract] [Full Text] [Related]

  • 25. Cis effect of the type 5 adenovirus E1A gene enhancer element on cellular transformation.
    Herbst RS, Pelletier M, Babiss LE.
    J Cell Biochem; 1990 Jan; 42(1):33-44. PubMed ID: 2137130
    [Abstract] [Full Text] [Related]

  • 26. Cleavage of vimentin in dense cell cultures. Inhibition upon transformation by type 5 adenovirus.
    Ben-Ze'ev A, Babiss LE, Fisher PB.
    Exp Cell Res; 1986 Sep; 166(1):47-62. PubMed ID: 3017738
    [Abstract] [Full Text] [Related]

  • 27. Suppression of the progression phenotype in somatic cell hybrids occurs in the absence of altered adenovirus type 5 gene expression.
    Duigou GJ, Babiss LE, Iman DS, Shay JW, Fisher PB.
    Mol Cell Biol; 1990 May; 10(5):2027-34. PubMed ID: 2139170
    [Abstract] [Full Text] [Related]

  • 28. Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF).
    Fisher PB, Babiss LE, Weinstein IB, Ginsberg HS.
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3527-31. PubMed ID: 6954499
    [Abstract] [Full Text] [Related]

  • 29. Activation of adenovirus 5 E1A transcription by region E1B in transformed primary rat cells.
    Jochemsen AG, Peltenburg LT, te Pas MF, de Wit CM, Bos JL, van der Eb AJ.
    EMBO J; 1987 Nov; 6(11):3399-405. PubMed ID: 2962857
    [Abstract] [Full Text] [Related]

  • 30. Growth suppression and toxicity induced by caffeic acid phenethyl ester (CAPE) in type 5 adenovirus-transformed rat embryo cells correlate directly with transformation progression.
    Su ZZ, Lin J, Grunberger D, Fisher PB.
    Cancer Res; 1994 Apr 01; 54(7):1865-70. PubMed ID: 7511055
    [Abstract] [Full Text] [Related]

  • 31. Highly efficient focus formation by Rous sarcoma virus on adenovirus type 12 E1A-transformed rat 3Y1 cells.
    Shiroki K, Hamaguchi M, Kawai S.
    J Virol; 1992 Mar 01; 66(3):1449-57. PubMed ID: 1310757
    [Abstract] [Full Text] [Related]

  • 32. C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunity.
    Urbanelli D, Sawada Y, Raskova J, Jones NC, Shenk T, Raska K.
    Virology; 1989 Dec 01; 173(2):607-14. PubMed ID: 2531954
    [Abstract] [Full Text] [Related]

  • 33. Morphological transformation of human adenoviruses is determined to a large extent by gene products of region E1a.
    van den Elsen PJ, Houweling A, van der Eb AJ.
    Virology; 1983 Nov 01; 131(1):242-6. PubMed ID: 6606259
    [Abstract] [Full Text] [Related]

  • 34. c-fos is a positive regulator of carcinogen enhancement of adenovirus transformation.
    Su ZZ, Yemul S, Stein CA, Fisher PB.
    Oncogene; 1995 May 18; 10(10):2037-49. PubMed ID: 7761104
    [Abstract] [Full Text] [Related]

  • 35. Autoregulation of adenovirus E1A gene expression.
    Tibbetts C, Larsen PL, Jones SN.
    J Virol; 1986 Mar 18; 57(3):1055-64. PubMed ID: 2936896
    [Abstract] [Full Text] [Related]

  • 36. Recombinant human adenoviruses containing hybrid adenovirus type 5 (Ad5)/Ad12 E1A genes: characterization of hybrid E1A proteins and analysis of transforming activity and host range.
    Jelinek T, Graham FL.
    J Virol; 1992 Jul 18; 66(7):4117-25. PubMed ID: 1534849
    [Abstract] [Full Text] [Related]

  • 37. Transformation properties of type 5 adenovirus mutants that differentially express the E1A gene products.
    Haley KP, Overhauser J, Babiss LE, Ginsberg HS, Jones NC.
    Proc Natl Acad Sci U S A; 1984 Sep 18; 81(18):5734-8. PubMed ID: 6091106
    [Abstract] [Full Text] [Related]

  • 38. Activation and inhibition of expression of the 72,000-Da early protein of adenovirus type 5 in mouse cells constitutively expressing an immediate early protein of herpes simplex virus type 1.
    Tremblay ML, Yee SP, Persson RH, Bacchetti S, Smiley JR, Branton PE.
    Virology; 1985 Jul 15; 144(1):35-45. PubMed ID: 2998046
    [Abstract] [Full Text] [Related]

  • 39. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May 15; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 40. Dependence of tumor-forming capacities of cells transformed by recombinants between adenovirus types 5 and 12 on expression of early region 1.
    Shiroki K, Maruyama K, Saito I, Fukui Y, Yazaki K, Shimojo H.
    J Virol; 1982 May 15; 42(2):708-18. PubMed ID: 7086973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.